Valuation: ResMed, Inc.

Market Cap 3.24TCr 2.81TCr 2.63TCr 2.4TCr 4.52TCr 3,09300Cr 4.59TCr 31TCr 12TCr 1,54800Cr 12TCr 12TCr 5,16500Cr P/E 2026
18.7x
P/E 2027 * 19.5x
Enterprise Value 3.16TCr 2.73TCr 2.56TCr 2.34TCr 4.4TCr 3,01000Cr 4.47TCr 30TCr 12TCr 1,50600Cr 12TCr 12TCr 5,02600Cr EV / Sales 2026
4.84x
EV / Sales 2027 * 5.42x
Free-Float
75.62%
Yield 2026
1.26%
Yield 2027 * 1.18%
1 day+2.18%
1 week+0.76%
Current month+6.57%
1 month+10.29%
3 months+13.12%
6 months-13.40%
Current year-6.66%
1 week 202
Extreme 202
226.12
1 month 190.21
Extreme 190.21
226.12
Current year 180.26
Extreme 180.265
277.67
1 year 180.26
Extreme 180.265
293.81
3 years 132.24
Extreme 132.24
293.81
5 years 132.24
Extreme 132.24
301.34
10 years 56.59
Extreme 56.59
301.34
Manager TitleAgeSince
Chief Executive Officer 53 01/03/2013
Director of Finance/CFO 40 04/05/2026
Compliance Officer - 01/01/2018
Director TitleAgeSince
Director/Board Member 78 01/01/2005
Chairman 53 25/01/2023
Chairman 83 01/06/1989
Date Insider Type Main position Quantity % Market Cap.
07/08/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
05/08/26 Sell

Founder

-8,000 0.0055%
07/07/26 Fiscal year

Chief Executive Officer

14,973 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
+2.18%+0.76%-20.92%+25.28% 3.24TCr
+0.89%+7.13%+30.84%+11.26% 22TCr
-0.92%+6.50%+3.84%-18.78% 15TCr
+2.00%+8.95%-14.97%+31.77% 14TCr
+1.45%+4.28%-50.18%+0.31% 7.42TCr
+1.77%+4.53%+19.83%+17.94% 5.4TCr
-0.48%+0.25%-14.98%-16.49% 5.09TCr
+0.52%+7.39%+30.98%+17.84% 4.22TCr
+0.78%+4.78%+48.59%+42.29% 4.07TCr
-0.26%+3.54%-0.34%+1.62% 3.29TCr
Average +0.79%+220.33%+3.27%+11.30% 8.39TCr
Weighted average by Cap. +0.77%+309.24%+5.39%+9.28%

Financials

2026 2027 *
Net sales 564.84Cr 489.49Cr 458.25Cr 418.12Cr 786.82Cr 54TCr 800.04Cr 5.37TCr 2.11TCr 27TCr 2.12TCr 2.07TCr 90TCr 581.23Cr 503.7Cr 471.54Cr 430.25Cr 809.65Cr 55TCr 823.26Cr 5.53TCr 2.17TCr 28TCr 2.18TCr 2.13TCr 93TCr
Net income 154.05Cr 133.5Cr 124.98Cr 114.04Cr 214.6Cr 15TCr 218.2Cr 1.47TCr 574.18Cr 7.35TCr 578.43Cr 565.83Cr 25TCr 162.85Cr 141.12Cr 132.11Cr 120.55Cr 226.84Cr 16TCr 230.66Cr 1.55TCr 606.95Cr 7.77TCr 611.44Cr 598.12Cr 26TCr
Net Debt -88Cr -76Cr -71Cr -65Cr -122.17Cr -8.37TCr -124.23Cr -834.31Cr -326.88Cr -4.19TCr -329.31Cr -322.13Cr -14TCr -95Cr -82Cr -77Cr -70Cr -132.14Cr -9.05TCr -134.36Cr -902.37Cr -353.55Cr -4.53TCr -356.17Cr -348.41Cr -15TCr
Logo ResMed, Inc.
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.
Employees
10,600
Date Price Change Volume
11/26/11 $224.84 +2.18% 12,39,266
10/26/10 $220.05 +3.83% 17,15,960
07/26/07 $211.94 -5.06% 38,10,438
06/26/06 $223.24 -0.35% 17,86,085
05/26/05 $224.03 +0.40% 17,46,578
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
224.84USD
Average target price
247.20USD
Spread / Average Target
+9.94%

Quarterly revenue - Rate of surprise